0001213900-14-000723.txt : 20140210 0001213900-14-000723.hdr.sgml : 20140210 20140210131454 ACCESSION NUMBER: 0001213900-14-000723 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140210 DATE AS OF CHANGE: 20140210 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MPHASE TECHNOLOGIES INC CENTRAL INDEX KEY: 0000825322 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] IRS NUMBER: 222287503 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-56929 FILM NUMBER: 14587439 BUSINESS ADDRESS: STREET 1: 587 CONNECTICUT AVE STREET 2: PO BOX 566 CITY: NORWALK STATE: CT ZIP: 06854 BUSINESS PHONE: 2038312212 MAIL ADDRESS: STREET 1: 587 CONNECTICUT AVE STREET 2: PO BOX 566 CITY: NORWALK STATE: CT ZIP: 06854 FORMER COMPANY: FORMER CONFORMED NAME: TECMA LABORATORIES INC DATE OF NAME CHANGE: 19980915 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DURANDO RONALD A CENTRAL INDEX KEY: 0001096217 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 43 ALEXANDER AVE CITY: NUTLEY STATE: NJ ZIP: 07110 SC 13D/A 1 sc13d0214a1durando_mphase.htm AMENDMENT NO. 1 TO SCHEDULE 13D sc13d0214a1durando_mphase.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13D
AMENDMENT NO. 1
 
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO
RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a)
 
mPhase Technologies Inc.
(Name of Issuer)
 
COMMON STOCK, $.001 VALUE
(Title of Class of Securities)
 
62472C 10 2
(CUSIP Number)

Ronald A. Durando
mPhase Technologies Inc.
587 Connecticut Avenue
Norwalk, CT 06854
(203) 838-2741
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
 
February 10, 2014
(Date of Event Which Requires Filing of This Statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f), or 13d-1(g), check the following box:   ¨
 
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
 
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
Page 1 of 4 Pages
 
 
 
 
 
CUSIP No. 62472C 10 2
  13D
Page 2 of 4 Pages
 
1 
NAMES OF REPORTING PERSON
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
RONALD DURANDO
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
(a)  ¨       
(b)  ¨
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
OO
5
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)    x
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States of America
Number of
shares
beneficially
owned by
each
reporting
person
with
 
7
SOLE VOTING POWER
 
99,968,613 shares inclusive of options and to purchase shares of common stock
8
SHARED VOTING POWER
 
140,000,000 shares owned by Karen Durando, his wife
9
SOLE DISPOSITIVE POWER
 
99,968,613 shares inclusive of options and convertible notes to purchase shares of common stock
10
SHARED DISPOSITIVE POWER
 
140,000,000 shares owned by Karen Durando, his wife
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
239,968,613 **
12
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) x
 
Does not include 12% convertible notes in the aggregate principal amount of $603,371,89 convertible into 1,508,429,729 shares of common stock at $.0004 per share contingent upon the availability of sufficient authorized shares. *
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
3.3% *
14
TYPE OF REPORTING PERSON
 
IN
 
** Inclueds 42,726,686 shares owned by MicroPhase Corporation
 
 
 
 
 
CUSIP No. 62472C 10 2
  13D
Page 3 of 4 Pages
 
The following constitutes the Schedule 13D filed by the Undersigned (the “Schedule 13D”).
 
 
Item 1. 
Security and the Issuer.
 
This Statement on Schedule 13D (“Statement”) is filed with respect to the Common Stock, $.001 value of mPhase Technologies, Inc. (the “Issuer”), whose principal executive offices are located at 587 Connecticut Avenue, Norwalk, Connecticut 06854-0566. Such class of securities is hereinafter referred to as “Common Stock”.
 
 
Item 2. 
Identity and Background.
 
Items 2(a), 2(b), 2(c) This Statement is filed by Ronald Durando. Mr.  Durando is a Director and the  President  and Chief Executive  Officer of the Issuer. The principal place of business for mPhase Technologies Inc. is 587 Connecticut Avenue, Norwalk, Connecticut 06854-0566.

2(d), 2(e) During the past five years, Mr. Durando has not been (a) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (b) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction  as a result of which such person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. On October 19, 2007, Mr. Durandoi was subject to an SEC Consent Decree which is referenced in prior 13D and other filings.

2(f) Mr. Durando is a United States Citizen.

 
Item 3. 
Source and Amount of Funds or Other Consideration.
 
N/A
 
 
Item 4. 
Purpose of Transaction.
 
On January 17, 2014 Mr. Durando received 40 million shares  of common stock of the issuer in exchange for cancellation of $16,000 of debt owed by the issuer to Mr. Durando. Mr. Durando transferred such shares to his wife Karen Durando.
 
 
Item 5. 
Interest in Securities of the Issuer.
  
5(a) and (b) Mr.Durando beneficially owns an aggregate of 239,968,613 shares of Common Stock. Mr Durando has the sole power to vote or direct the vote and to dispose or direct the disposition of those shares directly and beneficially owned thereby. Mr. Durando beneficially owns directly 99,968,613 shares of Common Stock,, and Karen Durando (his wife) owns 140,000,000 shares directly, representing in the aggregate 3.3% of the total outstanding shares of the Common Stock.
 
5(c) During the past 60 days Mr.Durando purchased 0 shares of common stock in the open market.
 
5(d) No person other than Mr.Durando is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, such shares of Common Stock.
 
Item 5(e) Not applicable.
 
 
Item 6. 
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
 
None
 
 
Item 7. 
Material to be filed as Exhibits.
 
None

 
 
 
 
CUSIP No. 62472C 10 2
  13D
Page 4 of 4 Pages
 
SIGNATURES
 
After due inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information on set forth in this statement is true, complete and correct.
 
Dated: February 10, 2014
By:
/s/ Ronald Durando
   
Ronald Durando